Cobro Ventures
Venture Capital
Active
McLean, United States
15
26M
10
6
0.27
4
- Stages of investment
- Areas of investment
Summary
Opposing the other organizations, this Cobro Ventures works on 4 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2019. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Cobro Ventures, startups are often financed by Korea Investment Partners, Emigrant Capital, U.S. Department of Defense. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, Korea Investment Partners, Emigrant Capital. In the next rounds fund is usually obtained by Taiwania Capital, U.S. Department of Defense, RTW Investments LLC.
The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight C4 Therapeutics, Frequency Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Medical. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
This organization was formed by Marc Cohen.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 15
- Lead investments
- 6
- Exits
- 4
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (12)
- Medical (7)
- Therapeutics (5)
- Health Care (4)
- Genetics (3) Show 9 more
- Investments by region
-
- United States (13)
- Israel (1)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 100M
- Group Appearance index
- 0.80
- Avg. company exit year
- 17
- Avg. multiplicator
- 6.61
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AI Proteins | 03 Nov 2022 | Biotechnology, Artificial Intelligence, Therapeutics | Seed | 18M | United States, Massachusetts, Andover |
| Mana Therapeutics | 18 Oct 2018 | Biotechnology | Seed | 0 | United States, Virginia, Arlington |
| ten3T | 14 Dec 2016 | Health Care, Medical Device, Medical | Seed | 0 | Karnataka, Bengaluru, India |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.